Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

1.

Prospective randomized trial to assess effects of continuing hormone therapy on cerebral function in postmenopausal women at risk for dementia.

Rasgon NL, Geist CL, Kenna HA, Wroolie TE, Williams KE, Silverman DH.

PLoS One. 2014 Mar 12;9(3):e89095. doi: 10.1371/journal.pone.0089095. eCollection 2014.

PMID:
24622517
[PubMed - in process]
Free PMC Article
2.

Association between dopamine D4 receptor polymorphism and age related changes in brain glucose metabolism.

Volkow ND, Tomasi D, Wang GJ, Telang F, Fowler JS, Goldstein RZ, Klein N, Wong C, Swanson JM, Shumay E.

PLoS One. 2013 May 22;8(5):e63492. doi: 10.1371/journal.pone.0063492. Print 2013.

PMID:
23717434
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease.

Protas HD, Chen K, Langbaum JB, Fleisher AS, Alexander GE, Lee W, Bandy D, de Leon MJ, Mosconi L, Buckley S, Truran-Sacrey D, Schuff N, Weiner MW, Caselli RJ, Reiman EM.

JAMA Neurol. 2013 Mar 1;70(3):320-5.

PMID:
23599929
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

CREB regulates the expression of neuronal glucose transporter 3: a possible mechanism related to impaired brain glucose uptake in Alzheimer's disease.

Jin N, Qian W, Yin X, Zhang L, Iqbal K, Grundke-Iqbal I, Gong CX, Liu F.

Nucleic Acids Res. 2013 Mar 1;41(5):3240-56. doi: 10.1093/nar/gks1227. Epub 2013 Jan 22.

PMID:
23341039
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy.

Liu CC, Kanekiyo T, Xu H, Bu G.

Nat Rev Neurol. 2013 Feb;9(2):106-18. doi: 10.1038/nrneurol.2012.263. Epub 2013 Jan 8. Erratum in: Nat Rev Neurol. 2013. doi: 10.1038/nmeurol.2013.32. Liu, Chia-Chan [corrected to Liu, Chia-Chen].

PMID:
23296339
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Apolipoprotein E, not fibrillar β-amyloid, reduces cerebral glucose metabolism in normal aging.

Jagust WJ, Landau SM; Alzheimer's Disease Neuroimaging Initiative.

J Neurosci. 2012 Dec 12;32(50):18227-33. doi: 10.1523/JNEUROSCI.3266-12.2012.

PMID:
23238736
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals.

Lazarczyk MJ, Hof PR, Bouras C, Giannakopoulos P.

BMC Med. 2012 Oct 25;10:127. doi: 10.1186/1741-7015-10-127. Review.

PMID:
23098093
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

APOE genotype affects the pre-synaptic compartment of glutamatergic nerve terminals.

Dumanis SB, DiBattista AM, Miessau M, Moussa CE, Rebeck GW.

J Neurochem. 2013 Jan;124(1):4-14. doi: 10.1111/j.1471-4159.2012.07908.x. Epub 2012 Sep 28.

PMID:
22862561
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Characterizing the preclinical stages of Alzheimer's disease and the prospect of presymptomatic intervention.

Caselli RJ, Reiman EM.

J Alzheimers Dis. 2013;33 Suppl 1:S405-16. doi: 10.3233/JAD-2012-129026. Review.

PMID:
22695623
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Assessment of Alzheimer's disease risk with functional magnetic resonance imaging: an arterial spin labeling study.

Bangen KJ, Restom K, Liu TT, Wierenga CE, Jak AJ, Salmon DP, Bondi MW.

J Alzheimers Dis. 2012;31 Suppl 3:S59-74.

PMID:
22531427
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play.

Jack CR Jr.

Radiology. 2012 May;263(2):344-61. doi: 10.1148/radiol.12110433. Review.

PMID:
22517954
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Brain imaging in the study of Alzheimer's disease.

Reiman EM, Jagust WJ.

Neuroimage. 2012 Jun;61(2):505-16. doi: 10.1016/j.neuroimage.2011.11.075. Epub 2011 Dec 7. Review.

PMID:
22173295
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons.

Chen HK, Liu Z, Meyer-Franke A, Brodbeck J, Miranda RD, McGuire JG, Pleiss MA, Ji ZS, Balestra ME, Walker DW, Xu Q, Jeong DE, Budamagunta MS, Voss JC, Freedman SB, Weisgraber KH, Huang Y, Mahley RW.

J Biol Chem. 2012 Feb 17;287(8):5253-66. doi: 10.1074/jbc.M111.276162. Epub 2011 Dec 12.

PMID:
22158868
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Mild cognitive impairment: pathology and mechanisms.

Mufson EJ, Binder L, Counts SE, DeKosky ST, de Toledo-Morrell L, Ginsberg SD, Ikonomovic MD, Perez SE, Scheff SW.

Acta Neuropathol. 2012 Jan;123(1):13-30. doi: 10.1007/s00401-011-0884-1. Epub 2011 Nov 19. Review.

PMID:
22101321
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Positron emission tomography imaging of dementia.

Small GW.

Dialogues Clin Neurosci. 2000 Jun;2(2):168-9. No abstract available.

PMID:
22034203
[PubMed]
Free PMC Article
16.

Therapeutic approaches to age-associated neurocognitive disorders.

O'Hara R, Derouesné C, Fountoulakis KN, Yesavage JA.

Dialogues Clin Neurosci. 2001 Sep;3(3):191-213.

PMID:
22033831
[PubMed]
Free PMC Article
17.
18.

Age-related mild cognitive deficit: a ready-to-use concept?

Gilles C.

Dialogues Clin Neurosci. 2003 Mar;5(1):61-76.

PMID:
22033646
[PubMed]
Free PMC Article
19.

Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments.

Reiman EM, Langbaum JB, Fleisher AS, Caselli RJ, Chen K, Ayutyanont N, Quiroz YT, Kosik KS, Lopera F, Tariot PN.

J Alzheimers Dis. 2011;26 Suppl 3:321-9. doi: 10.3233/JAD-2011-0059. Review.

PMID:
21971471
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases.

Swerdlow RH.

Curr Pharm Des. 2011;17(31):3356-73. Review.

PMID:
21902672
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk